0001994145-23-000002.txt : 20230926 0001994145-23-000002.hdr.sgml : 20230926 20230926171426 ACCESSION NUMBER: 0001994145-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230926 DATE AS OF CHANGE: 20230926 EFFECTIVENESS DATE: 20230926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EnZeta Immunotherapies, Inc. CENTRAL INDEX KEY: 0001994145 IRS NUMBER: 932672754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-493090 FILM NUMBER: 231281211 BUSINESS ADDRESS: STREET 1: 122 SEVILLA AVE # 1814 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: 9173644613 MAIL ADDRESS: STREET 1: 122 SEVILLA AVE # 1814 CITY: CORAL GABLES STATE: FL ZIP: 33134 D 1 primary_doc.xml X0708 D LIVE 0001994145 EnZeta Immunotherapies, Inc. 122 SEVILLA AVE # 1814 CORAL GABLES FL FLORIDA 33134 9173644613 DELAWARE None None Corporation true 2023 Paul Kelly 122 Sevilla Avenue, Suite 1814 Coral Gables FL FLORIDA 33134 Executive Officer Director Traversa Sergio 2222 PONCE DE LEON BLVD. 3RD FLOOR Coral Gables FL FLORIDA 33134 Director Biotechnology Decline to Disclose 06b false 2023-09-08 false true Convertible Note false 5000 10000 10000 0 false 2 0 0 0 false EnZeta Immunotherapies, Inc. Paul Kelly Paul Kelly President 2023-09-22